MyFinsight
Home
Blog
About
Net comprehensive
loss
-$1,590,584
(23.05%↑ Y/Y)
Foreign currency
translation adjustment
$318,458
(148.73%↑ Y/Y)
Net loss
-$1,909,042
(-35.06%↓ Y/Y)
Loss before income
tax
-$1,909,042
Total other income
(expenses)
-$1,530,211
(-167.30%↓ Y/Y)
Loss from operations
-$378,831
(54.95%↑ Y/Y)
Change in the fair value
of obligation to...
$758,999
(1548.81%↑ Y/Y)
Change in the fair value
of derivative...
-$1,599,738
(-3544.89%↓ Y/Y)
Total operating
expenses
$240,385
(9.38%↑ Y/Y)
Gross loss
-$138,446
(77.71%↑ Y/Y)
Interest expense
$349,008
(-46.92%↓ Y/Y)
Imputed interest
expense
$293,463
Foreign exchange gain
(loss)
-$47,001
(-155.01%↓ Y/Y)
Revenue
$276,218
(19.26%↑ Y/Y)
Professional fees
$93,771
(6.29%↑ Y/Y)
General and
administrative
$82,739
(8.94%↑ Y/Y)
Royalty expense
$63,875
(14.89%↑ Y/Y)
Cost of goods sold
$414,664
(-51.38%↓ Y/Y)
Back
Back
Income Statement
CANNAPHARMARX, INC. (CPMD)
CANNAPHARMARX, INC. (CPMD)
source: myfinsight.com